Anti-Lung Cancer Activity of the Curcumin Analog JZ534 In Vitro

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2015 May 16

PMID 25977922

Citations 5

Authors

Jianzhang Wu

Zhijian Cai

Xiaoyan Wei

Minxiao Chen

Shilong Ying

Lingyi Shi

Ren-Ai Xu

Fan He

Guang Liang

Xiuhua Zhang

Affiliations

Soon will be listed here.

Abstract

This study investigated the anticancer effect of the curcumin analog JZ534 on lung cancer cell lines H460, A549, H1975, and HCC827. The antiproliferation effect of JZ534 was measured through the methylthiazoletetrazolium assay, and cell colony formation was observed. Cell cycle and apoptosis were determined by flow cytometry, and the preliminary mechanism was studied by Western blot. Results showed that JZ534 significantly inhibited the vitality and colony formation of lung cancer cells. JZ534 induced the G2/M cell cycle arrest of the cancer cells and suppressed the expression of cycle-related proteins, including cyclin B1 and Cdc2. Meanwhile, JZ534 induced cell apoptosis and upregulated the expression of apoptosis-related proteins, including cleaved caspase-3, Bax, and p53. At the same dose, JZ534 showed better antitumor activity than curcumin. These results suggest that JZ534 exhibits excellent anti-lung cancer activity by inhibiting the growth and inducing the apoptosis of lung cancer cells. Therefore, JZ534 is a promising lead compound for cancer treatment.

Citing Articles

On the health effects of curcumin and its derivatives.

Ayub H, Islam M, Saeed M, Ahmad H, Al-Asmari F, Ramadan M Food Sci Nutr. 2024; 12(11):8623-8650.

PMID: 39620006 PMC: 11606848. DOI: 10.1002/fsn3.4469.

Curcumin and Its Derivatives as Potential Antimalarial and Anti-Inflammatory Agents: A Review on Structure-Activity Relationship and Mechanism of Action.

Jamil S, Hamizah Ali A, Feroz S, Lam S, Kartini Agustar H, Abd Razak M Pharmaceuticals (Basel). 2023; 16(4).

PMID: 37111366 PMC: 10146798. DOI: 10.3390/ph16040609.

Rational design, synthesis, and pharmacological characterisation of dicarbonyl curcuminoid analogues with improved stability against lung cancer via ROS and ER stress mediated cell apoptosis and pyroptosis.

Wei T, Zheng Z, Wei X, Liu Y, Li W, Fang B J Enzyme Inhib Med Chem. 2022; 37(1):2357-2369.

PMID: 36039017 PMC: 9448362. DOI: 10.1080/14756366.2022.2116015.

HDAC Inhibitory and Anti-Cancer Activities of Curcumin and Curcumin Derivative CU17 against Human Lung Cancer A549 Cells.

Namwan N, Senawong G, Phaosiri C, Kumboonma P, Somsakeesit L, Samankul A Molecules. 2022; 27(13).

PMID: 35807258 PMC: 9268269. DOI: 10.3390/molecules27134014.

Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents.

Viegas F, Silva Gontijo V, de Freitas Silva M, Juliet Cristancho Ortiz C, Dos Reis Rosa Franco G, Ernesto J Curr Neuropharmacol. 2021; 20(7):1297-1328.

PMID: 34825873 PMC: 9881080. DOI: 10.2174/1570159X19666210712152532.

References

Choudhuri T, Pal S, Agwarwal M, Das T, Sa G . Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett. 2002; 512(1-3):334-40. DOI: 10.1016/s0014-5793(02)02292-5. View

Zheng A, Li H, Wang X, Feng Z, Xu J, Cao K . Anticancer effect of a curcumin derivative B63: ROS production and mitochondrial dysfunction. Curr Cancer Drug Targets. 2013; 14(2):156-66. DOI: 10.2174/1568009613666131126115444. View

Singh S, Khar A . Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem. 2006; 6(3):259-70. DOI: 10.2174/187152006776930918. View

Nagai S, Kurimoto M, Washiyama K, Hirashima Y, Kumanishi T, Endo S . Inhibition of cellular proliferation and induction of apoptosis by curcumin in human malignant astrocytoma cell lines. J Neurooncol. 2005; 74(2):105-11. DOI: 10.1007/s11060-004-5757-1. View

Ramachandran C, Rodriguez S, Ramachandran R, Nair P, Fonseca H, Khatib Z . Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res. 2005; 25(5):3293-302. View

Parkin D, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2):74-108. DOI: 10.3322/canjclin.55.2.74. View

Schmitt E, Steyaert A, Cimoli G, Bertrand R . Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells. Cell Death Differ. 1999; 5(6):506-16. DOI: 10.1038/sj.cdd.4400376. View

Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas P . Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998; 64(4):353-6. DOI: 10.1055/s-2006-957450. View

Spira A, Ettinger D . Multidisciplinary management of lung cancer. N Engl J Med. 2004; 350(4):379-92. DOI: 10.1056/NEJMra035536. View

10.

LeBlanc H, Lawrence D, Varfolomeev E, Totpal K, Morlan J, Schow P . Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat Med. 2002; 8(3):274-81. DOI: 10.1038/nm0302-274. View

11.

Lev-Ari S, Starr A, Vexler A, Karaush V, Loew V, Greif J . Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Anticancer Res. 2007; 26(6B):4423-30. View

12.

Kunnumakkara A, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal B . Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res. 2007; 67(8):3853-61. DOI: 10.1158/0008-5472.CAN-06-4257. View

13.

Aggarwal B, Sundaram C, Malani N, Ichikawa H . Curcumin: the Indian solid gold. Adv Exp Med Biol. 2007; 595:1-75. DOI: 10.1007/978-0-387-46401-5_1. View

14.

Kuttan G, Kumar K, Guruvayoorappan C, Kuttan R . Antitumor, anti-invasion, and antimetastatic effects of curcumin. Adv Exp Med Biol. 2007; 595:173-84. DOI: 10.1007/978-0-387-46401-5_6. View

15.

Sharma R, Steward W, Gescher A . Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol. 2007; 595:453-70. DOI: 10.1007/978-0-387-46401-5_20. View

16.

Anand P, Kunnumakkara A, Newman R, Aggarwal B . Bioavailability of curcumin: problems and promises. Mol Pharm. 2007; 4(6):807-18. DOI: 10.1021/mp700113r. View

17.

Anand P, Sundaram C, Jhurani S, Kunnumakkara A, Aggarwal B . Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett. 2008; 267(1):133-64. DOI: 10.1016/j.canlet.2008.03.025. View

18.

Lee Y, Park S, Kim Y, Park O . Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells. Ann N Y Acad Sci. 2009; 1171:489-94. DOI: 10.1111/j.1749-6632.2009.04699.x. View

19.

Abuzeid W, Davis S, Tang A, Saunders L, Brenner J, Lin J . Sensitization of head and neck cancer to cisplatin through the use of a novel curcumin analog. Arch Otolaryngol Head Neck Surg. 2011; 137(5):499-507. PMC: 3298372. DOI: 10.1001/archoto.2011.63. View

20.

Wang Y, Xiao J, Zhou H, Yang S, Wu X, Jiang C . A novel monocarbonyl analogue of curcumin, (1E,4E)-1,5-bis(2,3-dimethoxyphenyl)penta-1,4-dien-3-one, induced cancer cell H460 apoptosis via activation of endoplasmic reticulum stress signaling pathway. J Med Chem. 2011; 54(11):3768-78. DOI: 10.1021/jm200017g. View